1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legislation

Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform

 
• By Lauren Nardella

The Personal Care Products Council expects at least three cosmetics reform bills to make reappearances in the 115th Congress, but the best opportunity for updating regulations may involve tacking related provisions onto must-pass FDA user-fee bills this year. Top execs discussed the current legislative landscape during the “Washington Report” session of the trade group’s annual meeting in Palm Beach, Fla.

Capitol House

The cosmetics industry is “closer than we have ever been” in its efforts to modernize the US regulatory framework for cosmetics, but in the current political climate the best chance for reform may not be standalone cosmetics legislation, according to Personal Care Products Council leadership.

Rather, FDA user-fee legislation currently under development could be “our big shot” for updating cosmetics regulations, PCPC’s John Hurson, executive...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 
• By Malcolm Spicer

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By David Ridley

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

Senate Appropriators Give US FDA More Non-User Fee Funds Than House

 
• By Sarah Karlin-Smith

FDA would receive more funding for fiscal year 2026 in the Senate appropriations bill than its House counterpart, including $10m for unannounced foreign inspections.

Safer Beauty Bill Package Reintroduced in House to Close ‘Gaps’ Left by MoCRA

 
• By Eileen Francis

The Safer Beauty Bill Package comprises four federal bills introduced in the House that aim to close regulatory ‘gaps’ in cosmetics oversight left by the Modernization of Cosmetics Regulation Act.

More from Policy & Regulation

US FDA: No Replacement Yet For Animal Methods In Testing Systemic Effects Of Sunscreens

 
• By Lauren Nardella

While FDA fully supports the recent roadmap to reduce and eliminate animal testing, animal tests are still necessary for assessing systemic effects, says Jacqueline Corrigan-Curay, acting director for CDER, during a House Energy and Commerce Health Subcommittee hearing.

US House Passes ‘Do Not Flush’ Legislation For Non-Flushable Personal Care Wipes

 
• By Eileen Francis

The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.

EU Proposal To Simplify Hazardous Chemical Rules For Cosmetics ‘Step In Right Direction’ - Industry

 
• By Eileen Francis

The European Commission’s Simplification Omnibus published July 8 is ‘step in right direction’ for streamlining processes and providing more legal certainty and predictability for regulations addressing cosmetics, says Cosmetics Europe.